AAAAAA
Results:
1-13
|
Results: 13
Authors:
VALERO V
AZARNIA N
BUZDAR A
THERIAULST R
WILLEY J
LEE L
HORTOBAGYI G
Citation: V. Valero et al., A PHASE-II STUDY OF TLC D-99 (LIPOSOME-ENCAPSULATED DOXORUBICIN), IN COMBINATION WITH (5-FU) AND CYCLOPHOSPHAMIDE (CPA) IN THE TREATMENT OFMETASTATIC BREAST-CANCER (MBC), Annals of oncology, 9, 1998, pp. 65-65
Authors:
RAHMAN Z
BUZDAR A
HORTOBAGYI GN
Citation: Z. Rahman et al., PATIENT SELECTION IN HIGH-DOSE TRIALS OF BREAST-CANCER - REPLY, Journal of clinical oncology, 16(3), 1998, pp. 1239-1239
Authors:
GAJEWSKI J
RONDON G
MIRZA N
MEHRA R
DONATO M
ANDERLINI P
KORBLING M
THERIALT R
KHOURI I
GIRALT S
BUZDAR A
UENO N
PRZEPIORKA D
ANDERSSON B
DURRETT A
SALIBA R
BRUTON J
RAHMAN Z
IPPOLITI C
HORTABAQYI G
RABER M
BAST R
CHAMPLIN R
Citation: J. Gajewski et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC), Experimental hematology, 26(8), 1998, pp. 371-371
Authors:
BUZDAR A
Citation: A. Buzdar, THE PLACE OF CHEMOTHERAPY IN THE TREATMENT OF EARLY BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 16-20
Authors:
JONAT W
BUZDAR A
HOWELL A
WEBSTER A
STRUTT K
Citation: W. Jonat et al., SIGNIFICANTLY IMPROVED SURVIVAL WITH ARIMIDEX (ANASTROZOLE (A)) COMPARED WITH MEGESTROL-ACETATE (MA) IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER (ABC) - UPDATED RESULTS OF 2 RANDOMIZED TRIALS, European journal of cancer, 33, 1997, pp. 644-644
Authors:
INOUE T
KIM EE
WALLACE S
YANG DJ
WONG FCL
BASSA P
CHERIF A
DELPASSAND E
BUZDAR A
PODOLOFF DA
Citation: T. Inoue et al., POSITRON EMISSION TOMOGRAPHY USING [F-18] FLUOROTAMOXIFEN TO EVALUATETHERAPEUTIC RESPONSES IN PATIENTS WITH BREAST-CANCER - PRELIMINARY-STUDY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(4), 1996, pp. 235-245
Authors:
BUZDAR A
JONAT W
HOWELL A
JONES SE
BLOMQVIST C
VOGEL CL
EIERMANN W
WOLTER JM
AZAB M
WEBSTER A
PLOURDE PV
Citation: A. Buzdar et al., ANASTROZOLE, A POTENT AND SELECTIVE AROMATASE INHIBITOR, VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - RESULTS OF OVERVIEW ANALYSIS OF 2 PHASE-III TRIALS, Journal of clinical oncology, 14(7), 1996, pp. 2000-2011
Authors:
INOUE T
YANG DJ
ORIUCHI N
WALLACE S
BUZDAR A
TANSEY W
KIM EE
CHERIF A
KUANG LR
PODOLOFF DA
Citation: T. Inoue et al., POSITRON EMISSION TOMOGRAPHY WITH F-18 FLUOROTAMOXIFEN IN PATIENTS WITH BREAST-CANCER, The Journal of nuclear medicine, 37(5), 1996, pp. 335-335
Authors:
PAYNE JY
HOLMES F
COHEN PR
GAGEL R
BUZDAR A
DHINGRA K
Citation: Jy. Payne et al., PACLITAXEL - SEVERE MUCOCUTANEOUS TOXICITY IN A PATIENT WITH HYPERBILIRUBINEMIA, Southern medical journal, 89(5), 1996, pp. 542-545
Authors:
DHINGRA K
FRYE D
NEWMAN RA
WALTERS R
THERIAULT R
FRASCHINI G
SMITH T
BUZDAR A
HORTOBAGYI GN
Citation: K. Dhingra et al., PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF PIRARUBICIN IN COMBINATION WITH 5-FLUOROURACIL AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER, Clinical cancer research, 1(7), 1995, pp. 691-697
Authors:
JONAT W
BUZDAR A
HOWELL A
JONES S
BLOMQVIST C
VOGEL C
EIRMANN W
PLOURDE P
AZAB M
Citation: W. Jonat et al., 2 RANDOMIZED TRIALS ESTABLISHING EFFICACY AND TOLERABILITY OF ARIMIDEX (ZD1033) IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER (PABC), European journal of cancer, 31A, 1995, pp. 351-351
Authors:
DHINGRA K
FRITSCHE H
MURRAY JL
LOBUGLIO AF
KHAZAELI MB
KELLEY S
TEPPER MA
GRASELA D
BUZDAR A
VALERO V
BOOSER D
WHEALIN H
COLLINS TJ
PURSLEY JM
HORTOBAGYI G
Citation: K. Dhingra et al., PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF SUPPRESSION OF HUMAN ANTIMOUSE ANTIBODY-RESPONSE TO MONOCLONAL-ANTIBODY L6 BY DEOXYSPERGUALIN, Cancer research, 55(14), 1995, pp. 3060-3067
Authors:
DHINGRA K
VALERO V
GUTIERREZ L
THERIAULT R
BOOSER D
HOLMES F
BUZDAR A
FRASCHINI G
HORTOBAGYI G
Citation: K. Dhingra et al., PHASE-II STUDY OF DEOXYSPERGUALIN IN METASTATIC BREAST-CANCER, Investigational new drugs, 12(3), 1994, pp. 235-241
Risultati:
1-13
|